Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovative Diagnostics develops, manufactures, and markets serological and molecular diagnostic tests—primarily ELISA and PCR kits—for the detection of infectious zoonotic diseases in both humans and animals. Their veterinary product line under the brand "IDvet" offers one of the widest ranges of tests globally for animal health monitoring. The company’s products are used worldwide by public/private labs for disease surveillance, eradication campaigns, vaccination monitoring, and support “One Health” initiatives integrating human/animal/environmental health. They have a strong R&D focus with continuous new product launches but do not conduct clinical trials as they operate in diagnostics rather than therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovative Diagnostics.